##semicolon##
antiphospholipid syndrome, hemostasis, endothelial thrombocytopenia, markers,pregnancy.##submission.citations##
Balogun OO, da Silva Lopes K, Ota E, Takemoto Y, Rumbold A, Takegata M, Mori R. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev. 2016 May 6;2016(5):CD004073. doi: 10.1002/14651858.CD004073.pub4. PMID: 27150280; PMCID: PMC7104220.
Demidova E.M., Voloshuk I.N., Demidov B.S., Kazaryan S.M. Primenenie normal'nyh (polivalentnyh) vnutrivennyh immunoglobulinov v klinike nevynashivaniya beremennosti. Akush i gin 2013; 6: 44-47.
de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev. 2014 Jul 4;2014(7):CD004734. doi: 10.1002/14651858.CD004734.pub4. PMID: 24995856; PMCID: PMC6769058.
Kerchelaeva S.B. The value of antibodies to phospholipids and phospholipid-binding proteins in non-developing pregnancy // Russian Bulletin of obstetrician-gynecologist. 2003. - Volume 3, No. 4. - P.11 - 16.
Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017 Jan 31;1(1):CD007223. doi: 10.1002/14651858.CD007223.pub4. PMID: 28138973; PMCID: PMC6464743.
Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2020;320:1708
Polushkina E.S., SHmakov R.G. Rol' didrogesterona v privychnom nevynashivanii beremennosti. Medicinskij Sovet. 2020;(3):74-77. https://doi.org/10.21518/2079-701X-2020-3-74-77
Samigullina A.E., Kushubekova A.K. Analiz chastoty i struktury nevynashivaniya beremennosti // Sovremennye problemy nauki i obrazovaniya. – 2018. – № 6.;
Solieva N.K., Tuksonova D. I., Bobokulova S.B. The role of determining the study of D- Dimer parameters in predicting dic syndrome in women withantenatel fetal death// Аcademicia an international multidisciplinary research journal. - 2020. - №7. - P. 582-584.
Stirrat GM. Recurrent miscarriage. Lancet. 2010; 336: 673-5.CAS Article PubMed Google Scholar
Solieva N.K., Negmatullaeva M.N, Sultonova N.A. Features Of The Anamnesis Of Women With The Threat Of Miscarriage And Their Role In Determining The Risk Group// The American Journal of Medical Sciences and Pharmaceutical Research. - 2020. - № 2(09). - P. 32-34.
Schleussner E., Kamin G., Seliger G., Rogenhofer N., Ebner S., Toth B., Schenk M., Henes M., Bohlmann MK., Fischer T., Brosteanu O., Bauersachs R., Petroff D., ETHIG II group. Low-molecular-weight heparin for women with unexplained reccurent pregnancy loss: a multicentertrial with a minimization randomization scheme// Ann Inter Med. 2015 May 5;162(9): 601-9
Tuksanova Dilbar Ismatovna and Solieva Nozima Karimovna. The value of the immune status in miscarriage // Evropean Journal Of Pharmaceutical and Medical Research. - 2020. - №7 (6). - P. 117- 119.
Volgsten H, Jansson C, Darj E, Stavreus-Evers A. Women's experiences of miscarriage related to diagnosis, duration, and type of treatment. Acta Obstet Gynecol Scand. 2018 Dec;97(12):1491-1498. doi: 10.1111/aogs.13432. Epub 2018 Sep 21. PMID: 30063247.
Wahabi HA, Fayed AA, Esmaeil SA, Bahkali KH. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev. 2018 Aug 6;8(8):CD005943. doi: 10.1002/14651858.CD005943.pub5. PMID: 30081430; PMCID: PMC6513446.
Yuksel H., Kayatas S., Boza AT., Api M., Ertekin AA., Cam C. Low molecular weight heparin use unexplained recurent miscarriage// Pak J Med Sci. 2014 Nov-Dec. 30(6)., 1232-7.
Zaripova D. and Sharipova R. Comparative evaluation of the use of aleandronic acid in menopausal women complicated by osteoporosis. European journal of biomedical and pharmaceutical sciences. 2020.Vol-7, issue-CAS Article PubMed Google Scholar
Zhang Y, Wang H, Pan X, Teng W, Shan Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis. PLoS One. 2017 Apr 17;12(4):e0175708. doi: 10.1371/journal.pone.0175708. PMID: 28414788; PMCID: PMC5393567.